# Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery

> **NCT04432337** · NA · WITHDRAWN · sponsor: **University Hospital Center of Martinique**

## Conditions studied

- Inflammatory Response
- Extracorporeal Circulation; Complications
- Cardiac Surgery
- Type 2 Diabetes

## Interventions

- **PROCEDURE:** The role of the activation of the NLRP3 inflammasome after cardiac surgery

## Key facts

- **NCT ID:** NCT04432337
- **Lead sponsor:** University Hospital Center of Martinique
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Departure of the principal investigator
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432337, "Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04432337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
